Parkinson’s Disease and Medical Cannabis

Medical Cannabis as Part of a Parkinson’s Disease Treatment Plan

CITIVA plans to expand its research toward finding an effective way to alleviate the symptoms of Parkinson’s disease. CITIVA has been working on developing treatments based on the 1985 study conducted by Snider and Consroe. This study indicates that CDB is beneficial to Parkinson’s patients with Sinemet-induced dystonic dyskinesia.

Researchers have observed that THC and CBD, through vapor inhalation, help to alleviate the tremors and shakes associated with Parkinson’s disease.

Cannabis and Parkinson’s Disease- Videos, Articles and Studies




Understanding Parkinson’s Disease

Parkinson’s disease (PD) affects around one million people in the United States. Parkinson’s is a neurological disorder that affects movement. The symptoms worsen in their severity as the disease progresses. The causes of PD are unknown, and the disease is currently incurable. Even though there is no cure, medication and surgery are a few of the treatment options available. These treatments help people manage their symptoms.

Parkinson’s causes the malfunction and death of neurons, the brain’s nerve cells. These neurons, which are known as substantia nigra, are important to the functioning of the brain. The substantia nigra is responsible for producing dopamine, which sends messages to the parts of the brain that control movement and coordination. As Parkinson’s progresses, people lose their ability to control their body movements.

Symptoms of Parkinson’s Disease

Those who are suffering from Parkinson’s disease may exhibit some of the following symptoms:

    • Whispery, slow or slurred speech
    • Loss of bladder and bowel control, or frequent constipation
    • Slow movement (bradykinesia)
    • Tremors
    • Issues falling asleep during the day or frequent disruption of sleep throughout the night
    • Decreasing balance and balance control
    • Change in handwriting skills (handwriting becomes smaller and cramped)
    • Chewing and swallowing become difficult. There is an increased risk of choking. The increase in saliva production can result in drooling.
    • Cognitive problems (dementia), decline in intellectual capacity and hallucinations. Hallucinations occur in the advanced stages of Parkinson’
    • Changes in emotions may occur. A person may experience an increased level of fear, anxiety, isolation and depression.
    • Profuse sweating, sexual dysfunction, and general aches and pain.
Shaping the Future of Cannabinoid Medicine
In the


View Our


Meet the